A Novel Group of Potential Antituberculotic Agents: Antimycobacterial N-Benzylsalicylamides
Nová skupina potenciálních antituberkulotik: antimykobakteriální N-benzylsalicylamidy
V souvislosti s předchozí studií antimykobakteriálních sloučenin jsme připravili skupiny N-benzylsalicylamidůa vyhodnotili jsme jejich antimykobakteriální aktivitu proti kmenům Mycobacteriumtuberculosis, Mycobacterium kansasii a Mycobacterium avium. Získané údaje jsme analyzovaliFreeho-Wilsonovou metodou v porovnání s jejich izosterními analogy kyseliny 3-hydroxypikolinovéa 2-sulfanylbenzoové popsanými v předchozím sdělení.
Klíčová slova:
N-benzylsalicylamidy – mycobacterium – tuberkulostatika – QSAR
Authors:
K. Waisser; M. Peřina; I. Boudová; J. Kuneš; J. Kaustová 1
Authors‘ workplace:
Katedra anorganické a organické chemie Farmaceutické fakulty Univerzity Karlovy, Hradec Králové1 Oddělení pro diagnostiku mykobakterií – Krajská hygienická stanice, Ostrava
Published in:
Čes. slov. Farm., 2003; , 0
Category:
Overview
Linking up with a previous study of antimycobacterial compounds, several groups of N-benzylsalicylamideswere prepared and their antimycobacterial activities against the strains Mycobacteriumtuberculosis,Mycobacterium kansasii, and Mycobacterium aviumwere evaluated.The obtained datawere analyzed by Free-Wilson method in comparison with their isosteric analogues of 3-hydroxypicolinicand 2-sulfanylbenzoic acids described in the previous communication.
Key words:
N-benzylsalicylamides – mycobacterium – tuberculostatics – QSAR
Labels
Pharmacy Clinical pharmacologyArticle was published in
Czech and Slovak Pharmacy
2003 Issue 6
- FDA Warns Against Self-Monitoring Glucose Using Smartwatches. What About in Czechia?
- Distribution and Localization of Specifically Modified Exosomes Can Improve the Treatment of Muscular Dystrophies
- Long-term Keto Diet May Damage Our Organs
Most read in this issue
- Biological Effects of Resveratrol and Other Constituents of Wine
- A New Strategy of Therapeutic Drug Monitorining of Cyclosporine A Blood Levels inPatients after Renal Transplantation
- A Novel Group of Potential Antituberculotic Agents: Antimycobacterial N-Benzylsalicylamides
- Solubilization of Unilamellar Egg Yolk Phosphatidylcholine Liposomes by N-Alkyl-N,NdimethylamineN-oxides